Late phase completed clinical trials investigating bromocriptine mesylate quick release as treatment of type 2 diabetes mellitus
… by favorable safety profile: low risk of hypoglycemia and no weight … 2 diabetes. As a valuable additional benefit, bromocriptine is associated with significant cardiovascular risk reduction. …..... Read More